ES
31
3
LEN
52
2
PRU
62
5
VTR
54
5
AEE
64
4
UA
59
14
BXP
52
2
AVGO
22
2
WM
76
3
XRX
41
6
SEE
52
6
C
60
2
COP
54
-2
TEL
66
6
ALLE
44
7
FLS
75
2
CMS
60
2
K
57
4
CRM
65
6
BSX
70
2
ES
31
3
LEN
52
2
PRU
62
5
VTR
54
5
AEE
64
4
UA
59
14
BXP
52
2
AVGO
22
2
WM
76
3
XRX
41
6
SEE
52
6
C
60
2
COP
54
-2
TEL
66
6
ALLE
44
7
FLS
75
2
CMS
60
2
K
57
4
CRM
65
6
BSX
70
2
Financhill
Back

The Oncology Institute 10K Form

Sell
25

TOI
The Oncology Institute

Last Price:
0.15
Seasonality Move:
-19.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TOI News And Ratings

See the #1 stock for the next 7 days that we like better than TOI

TOI Financial Statistics

Sales & Book Value

Annual Sales: $324.24M
Cash Flow: $1.22M
Price / Cash Flow: 0
Annual Sales: $0.20
Price / Book: 0.76

Profitability

EPS (TTM): -0.78000
Net Income (TTM): $-70.24M
Gross Margin: $59.57M
Return on Equity: -163.45%
Return on Assets: -35.44%

The Oncology Institute Earnings Forecast

Key The Oncology Institute Financial Ratios

  • The Gross Profit Margin over the past 5 years for TOI is 18.37%.
  • The Selling, General & Administrative Expenses for TOI have been equal to 35.11% of Gross Profit Margin.
  • The Interest Expense is -8.16% of Operating Income.
  • The Net Earning history of TOI is -25.62% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

The Oncology Institute Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: TOI
Website: theoncologyinstitute.com

Debt

Debt-to-Equity Ratio: 5.91
Current Ratio: 2.49
Quick Ratio: 2.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TOI Technical Analysis vs Fundamental Analysis

Sell
25
The Oncology Institute (TOI) is a Sell

Is The Oncology Institute a Buy or a Sell?